home / stock / nby / nby news


NBY News and Press, NovaBay Pharmaceuticals Inc.

Stock Information

Company Name: NovaBay Pharmaceuticals Inc.
Stock Symbol: NBY
Market: NYSE
Website: novabay.com

Menu

NBY NBY Quote NBY Short NBY News NBY Articles NBY Message Board
Get NBY Alerts

News, Short Squeeze, Breakout and More Instantly...

NBY - NioBay Announces Closing of a Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, July 26, 2024 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“ NioBay ” or the “ Company ”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce th...

NBY - US Companies Moving the Markets, Evening edition
Fri, Jul 26, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) fell 20.2% to $0.03 on volume of 382,247,953 shares BurgerFi International Inc (BFI) rose 97.3% to $0.4205 on volume of 313,737,613 shares NVIDIA Corporation (NVDA) rose 0.7% to $113.06 on volume of 292,060...

NBY - US Companies Moving the Markets, Morning edition
Fri, Jul 26, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...

NBY - NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces 20% discounts on Avenova ® -branded eyecare products and product bundles during Amazon Prime Day being held July 16-17, 2024. “Prime Day has been a highly productive event for NovaBay in past years and convenient...

NBY - NovaBay Pharmaceuticals sees Q2 net revenue of $2.4M

2024-07-11 07:47:48 ET More on NovaBay NovaBay Pharmaceuticals receives NYSE notice for compliance NovaBay Pharmaceuticals show 13% rise in eyecare and wound care segment - prelim report Read the full article on Seeking Alpha For further details see: Nova...

NBY - NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Eyecare revenue for both the second quarter and the first half of 2024 increased by 9% over the comparable prior-year periods, driven by higher online sales The number of Avenova ® subscribers on Amazon increased by 64% since the beginning of 2023 and by 123% since the beginning ...

NBY - NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Partnership co-promoting NovaBay’s Avenova ® Antimicrobial Lid & Lash Solution to large ophthalmic surgery centers along with one of Eyenovia’s FDA-approved product MydCombi™ Preparing for Eyenovia's launch of clobetasol propionate ophthalmic suspension, ...

NBY - NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces it will be offering special promotions and discounts on its Avenova ® -branded eyecare products to customers and eyecare professionals throughout July in support of National Dry Eye Awareness Month. National Dry Eye Awarene...

NBY - First Phase of Exploration on Foothills Property Confirms Presence of High TiO2 Grades

MONTRÉAL, June 27, 2024 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is proud to announce that, following the start of exploration work on the Foothills project, assay results confirm the presence of high TiO 2 ...

NBY - NioBay Receives $500,000 Grant

MONTRÉAL, June 25, 2024 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is proud to announce the awarding of a grant as part of the 2 nd call for projects for critical and strategic minerals for its Crevier niobiu...

Next 10